Cizzle Biotechnology has signed a letter of intent with an NHS-linked diagnostics partner to begin UK validation of its CIZ1B lung cancer test. Executive Chairman Dr Allan Syms outlines how this complements their existing US licence and supports national early detection targets...
Soil results from Great Western Mining’s Huntoon claims in Nevada hint at something much bigger — a copper porphyry and tungsten system potentially linked over a 2.8 km trend. Executive Chairman Brian Hall explains why this could reshape the company's future...
One Health Group’s Chairman Derek Bickerstaff outlines another period of strong growth — with patient referrals, surgeons, and capacity all sharply higher...
Verge Technologies’ Jimmy Jobe reveals how AI-powered, self-healing database systems are eliminating the fragility of single-cloud dependence. With SentientDB at its core, Verge is building a future where enterprise data never goes dark...
Ilika plc CEO Graeme Purdy reveals the Goliath pilot line is now fully commissioned. With pouch cell assembly now live, the company is preparing for licensing deals and scale-up with industry partners. Watch the full interview now...
Volta Finance gives everyday investors access to outperforming private credit via CLOs — a space usually reserved for institutions. Analyst Mark Thomas breaks down the structural advantages, income strategy and manager performance behind the Hardman & Co report: “Liquid Access to Outperforming Private Credit”...
Thor Energy’s transformation is now paying off: CEO Andrew Hume outlines how three strategic deals — including a royalty play on uranium tailings and a major asset sale to TIVAN — have unlocked A$9M in value and cleared the runway for full-throttle hydrogen and helium exploration...
Ferro-Alloy Resources feasibility study for Phase 1 of its Balasausqandiq project in southern Kazakhstan, reveals costs that rank in the lowest 10% globally, and that’s before accounting for major optimisations and new revenue streams...
RECI offers something rare: liquid access to a booming but illiquid market. Harman & Co’s Mark Thomas explains how this unique real estate credit investor continues to provide strong returns through macro turbulence—with a model that hasn’t flinched in six years...
AW1 is more than just a battery project. David Taaffe explains how Ampeak Energy’s flagship development has triggered a domino effect across its multi-GWh pipeline — paving the way for £100 million in future annual revenues...
Strix Group is building momentum. CEO Mark Bartlett breaks down interim results and lays out why Billi’s growth, new product launches, and a financial calendar reset are helping the business steer through volatility — and why debt is set to fall sharply...
Boku Inc. CEO Stuart Neal joins us following a 34% jump in H1 revenues and surging mobile wallet usage. With Capital Markets Day approaching, Neal previews what’s driving growth and how the company is helping tech giants reach more paying users globally...
Manx Financial Group’s profits are surging, Payment Assist is flying, and a new high-margin fintech overdraft product is about to launch. Group FD James Smeed reveals how the company’s 2025 strategy is reshaping its lending engine and unlocking new revenue streams...
Cizzle Biotechnology is now in commercial motion, with its lung cancer diagnostic test entering clinical validation across North America. Backed by Cizzle Bio, OmniHealth, and the Moffitt Cancer Center, the company is moving from lab bench to nationwide rollout — with royalty payments already in hand...
Avingtrans CEO Steve McQuillan shares how AI, energy and infrastructure megatrends are driving record results — and why strategic deals could be back on the table in FY26...
Vassilios Carellas breaks down the latest performance from Kiln 1, explains what’s unlocking new revenue from previously discarded material, and reveals how a low-cost hydration circuit could unlock even more premium product lines...
Cizzle Biotechnology has signed a letter of intent with an NHS-linked diagnostics partner to begin UK validation of its CIZ1B lung cancer test. Executive Chairman Dr Allan Syms outlines how this complements their existing US licence and supports national early detection targets...
Soil results from Great Western Mining’s Huntoon claims in Nevada hint at something much bigger — a copper porphyry and tungsten system potentially linked over a 2.8 km trend. Executive Chairman Brian Hall explains why this could reshape the company's future...
One Health Group’s Chairman Derek Bickerstaff outlines another period of strong growth — with patient referrals, surgeons, and capacity all sharply higher...
Verge Technologies’ Jimmy Jobe reveals how AI-powered, self-healing database systems are eliminating the fragility of single-cloud dependence. With SentientDB at its core, Verge is building a future where enterprise data never goes dark...
Ilika plc CEO Graeme Purdy reveals the Goliath pilot line is now fully commissioned. With pouch cell assembly now live, the company is preparing for licensing deals and scale-up with industry partners. Watch the full interview now...
Volta Finance gives everyday investors access to outperforming private credit via CLOs — a space usually reserved for institutions. Analyst Mark Thomas breaks down the structural advantages, income strategy and manager performance behind the Hardman & Co report: “Liquid Access to Outperforming Private Credit”...
Thor Energy’s transformation is now paying off: CEO Andrew Hume outlines how three strategic deals — including a royalty play on uranium tailings and a major asset sale to TIVAN — have unlocked A$9M in value and cleared the runway for full-throttle hydrogen and helium exploration...
Ferro-Alloy Resources feasibility study for Phase 1 of its Balasausqandiq project in southern Kazakhstan, reveals costs that rank in the lowest 10% globally, and that’s before accounting for major optimisations and new revenue streams...
RECI offers something rare: liquid access to a booming but illiquid market. Harman & Co’s Mark Thomas explains how this unique real estate credit investor continues to provide strong returns through macro turbulence—with a model that hasn’t flinched in six years...
AW1 is more than just a battery project. David Taaffe explains how Ampeak Energy’s flagship development has triggered a domino effect across its multi-GWh pipeline — paving the way for £100 million in future annual revenues...
Strix Group is building momentum. CEO Mark Bartlett breaks down interim results and lays out why Billi’s growth, new product launches, and a financial calendar reset are helping the business steer through volatility — and why debt is set to fall sharply...
Boku Inc. CEO Stuart Neal joins us following a 34% jump in H1 revenues and surging mobile wallet usage. With Capital Markets Day approaching, Neal previews what’s driving growth and how the company is helping tech giants reach more paying users globally...
Manx Financial Group’s profits are surging, Payment Assist is flying, and a new high-margin fintech overdraft product is about to launch. Group FD James Smeed reveals how the company’s 2025 strategy is reshaping its lending engine and unlocking new revenue streams...
Cizzle Biotechnology is now in commercial motion, with its lung cancer diagnostic test entering clinical validation across North America. Backed by Cizzle Bio, OmniHealth, and the Moffitt Cancer Center, the company is moving from lab bench to nationwide rollout — with royalty payments already in hand...
Avingtrans CEO Steve McQuillan shares how AI, energy and infrastructure megatrends are driving record results — and why strategic deals could be back on the table in FY26...
Vassilios Carellas breaks down the latest performance from Kiln 1, explains what’s unlocking new revenue from previously discarded material, and reveals how a low-cost hydration circuit could unlock even more premium product lines...
